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SUMMARY
This thesis reviewed the current knowledge about the role of the VMB in pregnant women 
from sub-Saharan Africa. It also investigated the VMB composition and the infection status of 
five burdensome STIs (Chlamydia (C.) trachomatis, Neisseria (N.) gonorrhoeae, Trichomonas 
(T.) vaginalis, Mycoplasma (M.) genitalium, human papillomaviruses (HPV)) among pregnant 
women living in Pemba Island, Tanzania. On this matter, this thesis provides the latest insights 
into the burden of vaginal dysbiosis, vaginal dysbiotic conditions, and STIs during pregnancy 
in sub-Saharan Africa and Pemba Island, in particular.
Pregnancy is a delicate period in a woman’s life and pregnancy-related complications can be 
life-threatening for mothers and their children. Preterm birth, below average length for gesta-
tional age, low birthweight, pregnancy loss, and stillbirth are common pregnancy complications 
leading to morbidity and mortality among newborns. These complications are more common 
and more severe in middle and low-income countries, including sub-Saharan Africa. Several 
microorganisms ascending from the lower genital tract have been associated with adverse 
pregnancy outcomes. That is the case for diverse microorganisms (bacteria, fungi, viruses) able 
to colonize the vaginal environment. Such as the commensal vaginal microbiota (VMB) and 
microorganisms that can be transmitted after sexual contact, or sexually transmitted infections 
(STIs). Lactobacilli and other lactic acid-producing microorganisms in the VMB have been 
associated with a beneficial vaginal state. In contrast, an overgrowth of (facultative) anaerobes 
combined with a low abundance of Lactobacillus species (also known as vaginal dysbiosis) has 
been related to a less beneficial vaginal state.
Both vaginal dysbiosis, vaginal dysbiosis related conditions, and STIs such as C. trachoma-
tis, N. gonorrhoeae, T. vaginalis, M. genitalium, HPV, herpes simplex viruses, and Candida 
species, promote a non-beneficial pro-inflammatory vaginal state and relate to various health 
conditions for expectant mothers and fetus. A common vaginal related condition that has been 
linked to maternal and neonatal morbidity is bacterial vaginosis (BV). Multiple studies of 
antenatal clinic attendees in sub-Saharan Africa observed that up to 40% of women had BV. 
Simultaneously, between 2010 - 2015, the pooled prevalence of T. vaginalis, C. trachomatis, 
and N. gonorrhoeae during pregnancy ranged between 4.6 - 31.4%, 5 - 9%, and 2 - 5.2%, 
respectively. Furthermore, during pregnancy, prevalence rates between 5.4 - 46% for HPV and 
0.8 – 2.4% for M. genitalium have been reported in several independent studies from, and out-
side of, sub-Saharan Africa. Overall, it appears there is a high frequency of vaginal dysbiosis 
among women from sub-Saharan Africa or women with sub-Saharan ancestry. However, only 
limited data exists concerning the VMB composition during pregnancy, and new data for STI 
during pregnancy in rural settings of sub-Saharan Africa are still warranted. With this in mind, 
the burden of vaginal dysbiosis, VMB dysbiosis related conditions, and STI was investigated.
In the general introduction of this thesis, chapter 1, the VMB, its associated bacteria and condi-
tions, along with the five STIs (C. trachomatis, N. gonorrhoeae, T. vaginalis, M. genitalium, 
and HPV) are described and introduced. The research setting is also outlined in chapter 1. The 
vaginal samples from pregnant and post-delivery women analyzed in this thesis were previ-
ously collected and stored in a biobank in Pemba Island, Tanzania. Pemba Island is one of the 
largest Islands in the Zanzibar archipelago, with approximately 19744 pregnant women, and 
14000 annual births reported in 2018. Most inhabitants live below the UN poverty line, and the 
quality of antenatal and infant health care services remain poor. Limited data is available for 
STI burden among women from this Island, and to date, no information has been published on 
the VMB composition, particularly among pregnant women.
In chapter 2, the results of ten studies were systematically reviewed. These studies indepen-
dently show that a Lactobacillus-dominant VMB or VMB containing Lactobacilli are the most 
prevalent, followed by a more diverse anaerobe-dominant VMB among pregnant women in 
sub-Saharan Africa. If further speciated, a VMB profile dominated by L. iners or L. crispatus 
were observed as the most common Lactobacillus-dominant VMB among pregnancy in several 
populations. Most pregnant women with an STIs (C. trachomatis and T. vaginalis) also had 
a Lactobacillus-dominant VMB, but with a significantly higher presence of anaerobic spe-
cies in their VMB. For human immunodeficiency virus (HIV), another highly common STI in 
sub-Saharan Africa, one study reported an association between an anaerobic-dominant VMB, 
maternal HIV infection, and timing of antiretroviral therapy use before or during the pregnancy.
Moreover, use of probiotics (bacterial strains that can potentially modulate the microbiota) 
and other mineral or vitamin supplements with the VMB composition was also briefly ad-
dressed. Two of the included studies reported that the VMB did not differ between women who 
consumed probiotics and controls. Overall, the number of studies limited the evidence regard-
ing the effect of STIs, medication, and supplements on the VMB. Thus, the use and efficacy of 
Lactobacillus-based probiotics, medicine (antiretroviral therapy), and other supplements on the 
VMB among sub-Saharan pregnant women need to be further investigated.
Previous studies have linked VMB dysbiosis and dysbiotic conditions with various adverse 
pregnancy outcomes among different populations. To gain more insights into this association 
among sub-Saharan African women, chapter 3 systematically reviewed the findings of twelve 
studies that investigated this subject. However, merely one culture-based study from 1993 
reported about the relationship between VMB related bacteria and pregnancy outcomes. They 
observed that pregnant women in sub-Saharan Africa with VMB without Lactobacilli, or with 
overgrowth of other bacteria at the first antenatal examination, had 3.6 times higher risk of 
giving birth to a newborn with low birth weight (< 2 kg). This was in comparison women with 
a Lactobacillus-dominated VMB or mixed bacteria with a low abundance of Lactobacillus 
species. More studies were retrieved investigating the association between BV and several 
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adverse pregnancy outcomes among women from sub-Saharan Africa. An association between 
BV and preterm birth was most often reported (7/9 studies). None of the studies included 
found an association between BV and pregnancy loss (5/5) or intra-uterine growth retardation 
(1/1). Finally, there were discrepancies or a low number of studies to support the evidence 
between BV and low birthweight (2/6), PROM (2/4), intra-uterine infections (1/1), and small 
for gestational age (1/1). For another but a less well-known vaginal dysbiotic condition, aerobic 
vaginitis (AV), no article was retrieved that investigated its role with pregnancy outcomes 
in sub-Saharan African populations. Due to the considerable differences in study design and 
outcome reporting, the high burden of BV in sub-Saharan Africa, and the limited studies avail-
able on VMB composition and AV, additional research is needed to better determine the role of 
VMB dysbiosis, BV, and AV among sub-Saharan African women.
As highlighted earlier some sexually transmitted microorganisms can cause pregnancy-related 
sequelae. Thus, the burden of infections should continuously be monitored in vulnerable popu-
lations, such as pregnant women. In chapter 4, the burden of four non-viral STIs was inves-
tigated in vaginal samples from Muslim-Shirazi women between 16-48 years old in Pemba 
Island, Tanzania. In 55 vaginal samples from 439 (12.5%) local pregnant women, at least one 
STIs was detected. The prevalence of T. vaginalis (7.1%) was the highest, followed by C. tra-
chomatis (4.6%) and M. genitalium (2.1%). The presence of N. gonorrhoeae was not detected.
In chapter 5 the (natural) course of the four genital pathogens in pregnant women from Pemba 
Island were investigated. When compared to chapter 4, more vaginal samples across two time-
points (before 20 gestational (GA) weeks and after 20 GA weeks) during pregnancy and one 
timepoint post-delivery (42-62 days after parturition) were investigated for the presence and 
persistence of STIs across timepoints. N. gonorrhoeae was detected in vaginal samples from 
two different women. This further analysis provided evidence of this pathogen’s presence in 
Pemba Island’s local population. Interestingly, during pregnancy, the combined prevalence of 
STI was higher at the second timepoint (n = 385; 16.7%) compared to the prevalence at the first 
timepoint (n = 257, 12.2%). Moreover, in 44 post-delivery samples, the prevalence of T. vagi-
nalis (6.8%) was the highest, followed by C. trachomatis (2.3%), and N. gonorrhoeae (2.3%), 
while M. genitalium was not detected at this timepoint. Owing to the low prevalence of N. 
gonorrhoeae, its natural history could not be determined. Some women cleared off T. vaginalis 
(n = 11; 18%) and M. genitalium (n = 4; 25%) infections within ten weeks following initial 
detection during pregnancy. Clearance post-delivery was observed for T. vaginalis (n = 5; 80%) 
approximately 22 weeks after the last detection in pregnancy. Persistence for C. trachomatis 
during (n = 11) or after pregnancy (n = 1) was observed in all of the vaginal samples from the 
infected women. The study cohort size was small; therefore, careful extrapolation of results is 
recommended. However, the findings in chapter 5 support the need for further investigation 
in a bigger cohort, and the usage of biobanked samples is a valuable approach in this sense.
The burden of 15 high-risk HPV (hrHPV) genotypes among local pregnant women in Pemba 
were further investigated in Chapter 6. The prevalence of high-risk HPV was between 5.9% 
and 11.2% in pregnant women in Pemba Island, Tanzania. The persistence rate for high-risk 
HPV during pregnancy was high (63.6%) in this Tanzanian cohort. For future implementation 
of this assay in resource-poor setting, it is worth mentioning that the HPV detection kit used 
in Chapter 6 does not require additional DNA extraction or purification. Additionally, it is 
based on an isothermal amplification system to amplify targeted sequences in the different 
HPV genotype regions. This is an example of a simple sample processing procedure method 
that might be helpful for HPV screening in clinical diagnostic settings, especially in resource-
limited laboratories.
The findings in chapter 7 show for the first time that among the tested pregnant women from 
Pemba Island, the VMB was generally Lactobacillus dominant during pregnancy (65% before 
20 GA weeks and 81% after 20 GA weeks) and non-Lactobacillus dominant (74%) postdeliv-
ery. During pregnancy, the most common Lactobacillus species were L. crispatus at the first 
timepoint (26.5%; the prevalence was 1.5% higher than L. iners) and L. iners at the second 
timepoint (42.5%). VMB richness (number of species) significantly decreased during preg-
nancy, while the VMB diversity (number of species and their relative abundance, assessed by 
the Shannon diversity index) significantly increased between the second pregnancy timepoint 
and post-delivery. Data from matched samples show that in almost 50% of the women (n = 
38) tested at both timepoints the VMB shifted profile during pregnancy. This shift was most 
commonly towards an L. iners dominant VMB. From the second pregnancy to post-pregnancy 
timepoints, a switch to a diverse VMB community accounted for 85% of these changes. Several 
pathobionts (VMB related bacteria with potential pathological sequelae) were identified in the 
tested samples, with Klebsiella species and Streptococcus anginosus as the most prevalent dur-
ing and after pregnancy. The substantial presence of pathobionts was most commonly detected 
in diverse, non-Lactobacillus dominant VMB, followed by L. iners dominant VMB. There was 
a higher frequency of pathobionts and a substantial presence (higher relative abundance) of 
pathobionts in vaginal samples collected post-delivery compared to samples collected during 
pregnancy. At the second timepoint during pregnancy, significantly more women carrying a 
genital pathogen (HPV, C. trachomatis, T. vaginalis, and M. genitalium) had VMB belonging 
to by L. iners dominant VMB. Evidence from this study enhances the understanding of VMB 
during pregnancy and in the post-delivery period in a (rural) sub-Saharan African population.
Based on the evidence of the vaginal environment friends (lactic-acid producing microbes, 
such as most species belonging to Lactobacillus genus and particularly L. crispatus), enemies 
(STIs), and frenemies or everything in between (e.g., pathobionts) during pregnancy and after 
pregnancy, a general discussion and recommendation of this thesis are provided in chapter 8.
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A high frequency of non-Lactobacillus dominant VMB is reported among pregnant women 
living in sub-Saharan Africa, including Pemba Island, Tanzania. Furthermore, among Pemban 
women, the burden of viral, bacterial and protozoan STIs were also revealed during and after 
pregnancy. Post-pregnancy, most women in Pemba had a diverse, non-Lactobacillus dominant, 
VMB profile. Various hosts (including host-genetics, hormonal and inflammatory response), 
microbial, behavioural, sociodemographic, nutritional, and environmental factors directly or 
indirectly influence VMB composition and susceptibility to STIs in pregnancy. However, mi-
crobiology methods to detect microorganisms in the vaginal space, and a consensus approach 
to characterize the VMB profiles, should be further developed to provide more and improved 
evidence-based VMB and STIs related research, including for resources-limited settings. An 
integrated approach involving different stakeholders (researchers, clinicians, and policymakers) 
should be considered to implement better research, policy and management strategies. These 
efforts are crucial to improve female and newborn health globally, particularly in sub-Saharan 
Africa, with implications for society and future generations.
VALORIZATION 
RELEVANCE AND SOCIETAL IMPACT
This thesis provides knowledge generation around cutting-edge microbiome research - the vaginal 
microbiota (VMB) - and information on prevalence status of some the most fastidious and long-
lasting sexually transmitted infections (STIs) in sub-Saharan African women. Via a systematic 
search our work confirms that for most of the pregnant women living in sub-Saharan Africa, 
the VMB composition is Lactobacillus dominant (chapter 2). This is also the case among the 
pregnant women in Pemba Island, Tanzania, this thesis’s chosen research setting (chapter 7). In 
this very same population, Chlamydia (C.) trachomatis, Neisseria (N.) gonorrhoeae, Trichomonas 
(T.) vaginalis, Mycoplasma (M.) genitalium, and human papillomaviruses (HPV) was present 
during and after parturition (chapter 4-7). Moreover, a high frequency of VMB dysbiosis 
(defined as non-Lactobacillus dominant VMB) was observed post-delivery in this population 
(chapter 7). These findings expand scientific knowledge, for clinicians, researchers, and public 
health officials, on vastly under-research topics: vaginal conditions (vaginal dysbiosis, bacterial 
vaginosis, and aerobic vaginitis) and STIs in low- and middle-income countries, especially those 
belonging to the STI endemic areas in sub-Saharan Africa. It also highlights their burden in a 
vulnerable population, namely pregnant women. Therefore, it is essential to further research and 
monitor STIs’ burden and VMB composition in pregnant women, their role on health outcomes 
and implement up-to-date strategies to better control and eliminate STIs ad vaginal dysbiosis, 
particularly so during pregnancy. 
Regrettably, despite continued public health efforts, maternal and neonatal morbidity and mortality 
remain high in sub-Sahara Africa. There is also increasing evidence related to the contribution 
of STIs, VMB dysbiosis, or VMB dysbiotic conditions, such as bacterial vaginosis (BV) on 
maternal and neonatal morbidity (chapter 3). This evidence is yet to be confirmed in the Pemban 
population. Nevertheless, the novel scientific knowledge about the VMB composition in expectant 
and new mothers from Pemba should be used as a stepping stone for upcoming pregnancy and 
VMB-related research in sub-Saharan African communities (chapter 7). Additional research on 
this topic will ultimately provide evidence whether and how VMB composition is of clinical 
utility and can assist in making evidence-based VMB-related strategies to improve maternal and 
neonatal health. 
This work is part of a collaborative effort between the Institute of Public Health Genomics 
(Maastricht, the Netherlands), the Public health laboratory - Ivo de Carneri (Pemba Island, 
Tanzania) and the Center for Public Health Kinetics (India). This thesis provides the earliest 
testing results output of this collaboration (Chapter 4, 5,6  and 7). In order to maximize and 
continue this effort, different approaches will be sustained or further reinforced;  
